Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-833923 (XL-139), an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM).
説明 | BMS-833923 (XL-139), an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM). |
ターゲット&IC50 | BODIPY:21 nM |
別名 | XL-139 |
分子量 | 473.57 |
分子式 | C30H27N5O |
CAS No. | 1059734-66-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 88 mg/mL (185.8 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-833923 1059734-66-5 Apoptosis GPCR/G Protein Stem Cells Smo Hedgehog/Smoothened Inhibitor inhibit Smoothened XL 139 XL139 BMS 833923 XL-139 BMS833923 inhibitor